Autocrine activation of canonical BMP signaling regulates PD‐L1 and PD‐L2 expression in human dendritic cells
- 17 January 2014
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 44 (4) , 1031-1038
Abstract
Bone morphogenetic proteins (BMPs) are multifunctional growth factors regulating differentiation and proliferation in numerous systems including the immune system. Previously, we described that the BMP signaling pathway is functional in human monocyte‐derived dendritic cells (MoDCs), which were found to express both the specific receptors and the Smad proteins required for signal transduction. In this study, we provide evidence that human MoDCs produce BMP‐4 and that this production is increased over the maturation process as is BMP signal transduction. When DCs are matured in the presence of an inhibitor of the BMP pathway, the expression of the maturation markers PD‐L1 and PD‐L2 is reduced, while cytokine production is not affected. As a result, these mature DCs present an augmented ability to stimulate both T cells and NK cells. Eventually, the inhibition of BMP signaling during maturation causes a reduced expression of IRF‐1, a transcription factor that positively regulates the expression of PD‐L1 and PD‐L2. The present study indicates that the BMP signaling pathway regulates PD‐L1 and PD‐L2 expression in human MoDCs during the maturation process, probably through the IRF‐1 transcription factor, and also points out that the manipulation of BMP signaling might considerably improve the immunogenicity of MoDCs used in immunotherapy.Keywords
Funding Information
- Ministerio de Economía y Competitividad (SAF2012-33180, BFU2010-18250)
- Instituto de Salud Carlos III (RD12/0019/0007)
- Comunidad de Madrid (S2010/BMD-2420)
This publication has 36 references indexed in Scilit:
- Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic CellsFrontiers in Immunology, 2013
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibodyBlood, 2010
- ERK/p38 MAP‐kinases and PI3K are involved in the differential regulation of B7‐H1 expression in DC subsetsEuropean Journal of Immunology, 2009
- Directing Dendritic Cell Immunotherapy Towards Successful Cancer TreatmentImmunotherapy, 2009
- ActRIIA and BMPRII Type II BMP Receptor Subunits Selectively Required for Smad4-Independent BMP7-Evoked ChemotaxisPLOS ONE, 2009
- Bone morphogenetic protein receptors and signal transductionThe Journal of Biochemistry, 2009
- Effect of bone morphogenetic protein‐6 on macrophagesImmunology, 2009
- siRNA Knockdown of PD-L1 and PD-L2 in Monocyte-Derived Dendritic Cells only Modestly Improves Proliferative Responses to Gag by CD8+ T Cells from HIV-1-Infected IndividualsJournal of Clinical Immunology, 2009
- Bone morphogenetic protein‐2/4 signalling pathway components are expressed in the human thymus and inhibit early T‐cell developmentImmunology, 2007
- IRF family proteins and type I interferon induction in dendritic cellsCell Research, 2006